Chronic lymphocytic leukaemia genomics and the precision medicine era

Hussein Ghamlouch, Florence Nguyen-Khac, Olivier A. Bernard

    Research output: Contribution to journalReview articlepeer-review

    12 Citations (Scopus)

    Abstract

    Massive genomic analyses have underscored the diversity of chronic lymphocytic leukaemia (CLL) between patients. Genetic heterogeneity of tumour clones within a patient may fuel tumour evolution. Several recurrently deregulated intra-cellular pathways are candidates for targeted therapies that are very promising and are dramatically changing clinical patients’ perspectives. In this review we present an overview of the genetic and epigenetic features of CLL and their clinical and biological implications.

    Original languageEnglish
    Pages (from-to)852-870
    Number of pages19
    JournalBritish Journal of Haematology
    Volume178
    Issue number6
    DOIs
    Publication statusPublished - 1 Sept 2017

    Keywords

    • chronic lymphocytic leukaemia
    • mutations
    • targeted therapy
    • tumour evolution

    Cite this